Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.

We hypothesize that elevation of Nm23-H1 expression in micrometastatic breast cancer cells may inhibit their metastatic colonization and further invasion, and induce differentiation, thus resulting in a clinical benefit. The current study investigated the possible contribution of DNA methylation to the regulation of Nm23-H1 expression, based on the observation that two CpG islands are present in its promoter. 5-Aza-2'-deoxycytidine (5-Aza-CdR), a DNA methylation inhibitor, increased the Nm23-H1 expression of 5 of 11 human breast carcinoma cell lines in vitro, including 3 of 3 metastatically competent lines. Increased Nm23-H1 expression was accompanied by a reduction in motility in vitro, with minimal effect on proliferation. Both increased Nm23-H1 expression and decreased motility were observed using low (75 nM) concentrations of 5-Aza-CdR. Array analysis of MDA-MB-231 breast carcinoma cells treated with 5-Aza-CdR confirmed the elevation of nm23-H1 mRNA, whereas relatively few other genes exhibited altered expression. Bisulfite sequencing of the two CpG islands in a panel of cell lines and in 20 infiltrating ductal carcinomas revealed that one island (-3090 bp to -3922 bp) exhibited infrequent differential methylation. The data indicate that DNA methylation inhibitors can directly or indirectly cause both elevation of Nm23-H1 expression and decreased function in one aspect of metastasis, motility.

[1]  S. Hellman,et al.  Individual characterisation of the metastatic capacity of human breast carcinoma. , 2000, European journal of cancer.

[2]  R. Blamey,et al.  INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  R. Todd,et al.  p12(DOC-1), a growth suppressor, associates with DNA polymerase alpha/primase. , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  R. Todd,et al.  p12DOC1, a growth suppressor, associates with DNA polymerase α/primase , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  P. Schedin,et al.  Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. , 2000, Cancer research.

[6]  P. Steeg,et al.  Nm23/Nucleoside Diphosphate Kinase in Human Cancers , 2000, Journal of bioenergetics and biomembranes.

[7]  H. Klein.  A radical solution to death , 2000, Nature Genetics.

[8]  T. Pandita,et al.  High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Widschwendter,et al.  Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. , 2000, Journal of the National Cancer Institute.

[10]  J. Hassell,et al.  Independent modulation of collagen fibrillogenesis by decorin and lumican , 2000, Cellular and Molecular Life Sciences CMLS.

[11]  J. Herman,et al.  Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. , 2000, Journal of the National Cancer Institute.

[12]  M. Hendrix,et al.  Epigenetic silencing of maspin gene expression in human breast cancers , 2000, International journal of cancer.

[13]  B. Tycko,et al.  Epigenetic gene silencing in cancer. , 2000, The Journal of clinical investigation.

[14]  G. Chenevix-Trench,et al.  Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. , 2000, Carcinogenesis.

[15]  J. Springer,et al.  Cloning and characterization of the Yarrowia lipolytica squalene synthase (SQS1) gene and functional complementation of the Saccharomyces cerevisiae erg9 mutation , 2000, Yeast.

[16]  M. Caligiuri,et al.  Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.

[17]  Hui-li Chen,et al.  Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells , 2000, Journal of Cancer Research and Clinical Oncology.

[18]  M. Yutsudo,et al.  Isolation of Transformation Suppressor Genes by cDNA Subtraction: Lumican Suppresses Transformation Induced by v-src and v-K-ras , 2000, Journal of Virology.

[19]  T. Lüscher,et al.  Connective Tissue Growth Factor Induces Apoptosis in Human Breast Cancer Cell Line MCF-7* , 1999, The Journal of Biological Chemistry.

[20]  T. Amagasa,et al.  Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  J. Hudson,et al.  In vivo gene expression profile analysis of human breast cancer progression. , 1999, Cancer research.

[22]  D. Rimm,et al.  PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin. , 1999, Journal of cell science.

[23]  A. Macleod,et al.  Down-regulation of Human DNA-(Cytosine-5) Methyltransferase Induces Cell Cycle Regulators p16 ink4A and p21WAF/Cip1 by Distinct Mechanisms* , 1999, The Journal of Biological Chemistry.

[24]  D. Sinnett,et al.  DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2'-deoxycytidine. , 1999, Anti-cancer drugs.

[25]  S. Rabbani,et al.  Transcriptional regulation of urokinase (uPA) gene expression in breast cancer cells: Role of DNA methylation. , 1999, International journal of cancer.

[26]  R. Gillies,et al.  Nm23‐transfected MDA‐mB‐435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: A 31P nuclear magnetic resonance study in vivo and in vitro , 1999, Magnetic resonance in medicine.

[27]  P. Goss,et al.  Examination of POU homeobox gene expression in human breast cancer cells , 1999, International journal of cancer.

[28]  R. Jirtle,et al.  Genomic imprinting: implications for human disease. , 1999, The American journal of pathology.

[29]  D. Rimm,et al.  PECAM-1 ( CD 31 ) functions as a reservoir for and a modulator of tyrosine-phosphorylated β-catenin , 1999 .

[30]  H. Lee,et al.  Inhibition of colonization and cell-matrix adhesion after nm23-H1 transfection of human prostate carcinoma cells. , 1998, Cancer letters.

[31]  W. Stadler,et al.  Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases. , 1998, Cancer research.

[32]  Q. Al-Awqati,et al.  An endothelial growth factor involved in rat renal development. , 1998, The Journal of clinical investigation.

[33]  N. Brünner,et al.  Relationship of nm23 to proteolytic factors, proliferation and motility in breast cancer tissues and cell lines. , 1998, British Journal of Cancer.

[34]  M. Namba,et al.  Reduced metastatic potential and c-myc overexpression of colon adenocarcinoma cells (Colon 26 line) transfected with nm23-R2/rat nucleoside diphosphate kinase alpha isoform. , 1998, International journal of molecular medicine.

[35]  S. Hellman,et al.  The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer. , 1998, Cancer research.

[36]  D. Wong,et al.  Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation , 1998, Molecular and Cellular Biology.

[37]  L. Murphy,et al.  Expression of lumican in human breast carcinoma. , 1998, Cancer research.

[38]  C. Morrow,et al.  Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells. , 1998, Gene.

[39]  P. Jones,et al.  Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. , 1998, Cancer research.

[40]  Supratik Das,et al.  Specific Interaction of Eukaryotic Translation Initiation Factor 5 (eIF5) with the β-Subunit of eIF2* , 1997, The Journal of Biological Chemistry.

[41]  E. Wilson,et al.  Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  N. Kirschbaum,et al.  Characterization of the human platelet/endothelial cell adhesion molecule-1 promoter: identification of a GATA-2 binding element required for optimal transcriptional activity. , 1997, Blood.

[43]  M. Szyf,et al.  Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Jaenisch,et al.  De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. , 1996, Development.

[45]  L. Gerace,et al.  Identification of novel M phase phosphoproteins by expression cloning. , 1996, Molecular biology of the cell.

[46]  S. Al-Sedairy,et al.  Effects of cytokine‐mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells , 2006, International journal of cancer.

[47]  J. Herman,et al.  E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. , 1995, Cancer research.

[48]  C. Kozak,et al.  Molecular Cloning, Characterization, and Genetic Mapping of the cDNA Coding for a Novel Secretory Protein of Mouse. DEMONSTRATION OF ALTERNATIVE SPLICING IN SKIN AND CARTILAGE (*) , 1995, The Journal of Biological Chemistry.

[49]  S. Baylin,et al.  Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. , 1995, Cancer research.

[50]  H. Tanaka,et al.  Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line. , 1995, Cancer research.

[51]  R. Weinberg,et al.  Suppression of intestinal neoplasia by DNA hypomethylation , 1995, Cell.

[52]  M J Bissell,et al.  A Novel Function for the nm23-Hl Gene: Overexpression in Human Breast Carcinoma Cells Leads to the Formation of Basement Membrane and Growth Arrest , 2010 .

[53]  S. Bryant,et al.  Eukaryotic translation elongation factor 1γ contains a glutathione transferase domain—Study of a diverse, ancient protein super family using motif search and structural modeling , 1994, Protein science : a publication of the Protein Society.

[54]  P. Steeg,et al.  NME1 protein expression and loss of heterozygosity mutations in primary human breast tumors. , 1994, Journal of the National Cancer Institute.

[55]  A. Bird,et al.  Number of CpG islands and genes in human and mouse. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[56]  P. Steeg,et al.  Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. , 1993, Oncogene.

[57]  P. Steeg,et al.  Inhibition of cell motility after nm23 transfection of human and murine tumor cells. , 1993, Cancer research.

[58]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[59]  A. Riggs,et al.  X-chromosome inactivation and cell memory. , 1992, Trends in genetics : TIG.

[60]  Robert Clarke,et al.  Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines , 1992, Journal of cellular physiology.

[61]  L. Liotta,et al.  Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm3-transfected melanoma cells , 1991, Cell.

[62]  J. Price,et al.  Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. , 1990, Cancer research.

[63]  L. Liotta,et al.  Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development , 1989, Nature.

[64]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.